Neogen Corporation
NASDAQ:NEOGMedical - Diagnostics & Research
+$0.16 today
- Market cap
- $2.42B
- Beta
- 1.80
- P/E (TTM)
- -3.3
- EPS (TTM)
- -$2.80
Volume 1.79M
Average 2.53M
NEOG Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Neogen CorporationNASDAQ: NEOG
Net Income · Q1 FY2027 · quarter ended Aug 2026
Net income turns negative
Q1 FY2027 net income was -$11.9M, compared with $36.34M a year earlier. Trailing-twelve-month net income was -$56.14M. Over 3 fiscal years it compounded at -29.8% a year.
Context
- Net income amounted to 0.9% of revenue in FY2026, down 121.2 pp from a year earlier.
- Net income grew in size in 1 of the last 3 fiscal years.
- FY2026 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 4 analysts of $70.29M (+989.7%) for the fiscal year ending May 2027, a step up from the -99.3% reported in FY2026.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterAug 2026
- -$11.9M+5.3% QoQ
- Last fiscal yearMay 2026
- -$7.9M-99.3% YoY
- LTMAug 2026
- -$56.14M-94.6% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -132.7% | +186.7% | +319.5 pp |
| 1 year | -99.3% | +989.7% | +1089.0 pp |
| 3-year CAGR | -29.8% | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2026
- (7.9M) USD
- Year-over-year change
- +99.3%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2026 | 2026-05-31 | (7.9M) | +99.3% |
| FY2025 | 2025-05-31 | (1.09B) | -11491.6% |
| FY2024 | 2024-05-31 | (9.42M) | +58.8% |
| FY2023 | 2023-05-31 | (22.87M) | -147.3% |
| FY2022 | 2022-05-31 | 48.31M | — |
Net Income vs competitors
How NEOG compares with its peers on the latest reported figures
- NEOG's LTM Aug 2026 net income of $56.14M is the smallest of the 7 companies compared; the peer median is $676.52M.
- Its year-over-year change of -94.6% is the 6th highest of 7, against a peer median of +7.1%.
- Net income amounts to 6.4% of revenue for NEOG, versus a peer median of 10.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $3.17B | -80.7% | +7.9% | 4.8% | |
| LTM Jun 2026 | $2.62B | -0.2% | +8.2% | 27.5% | |
| LTM Sep 2026 | $1.18B | +15.1% | +16.0% | 25.4% | |
| LTM Sep 2026 | $170.85M | +14.5% | +13.7% | 15.4% | |
| LTM Sep 2026 | $103M | -386.1% | +43.8% | 2.0% | |
| LTM Mar 2026 | $95.23M | +199.6% | -0.6% | 6.3% | |
| LTM Aug 2026 | $56.14M | -94.6% | -29.8% | 6.4% | |
| Peer median (excluding NEOG) | $676.52M | +7.1% | +10.9% | 10.9% | |
Competitors are the stored peer set for NEOG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 May 2022 | FY2023 May 2023 | FY2024 May 2024 | FY2025 May 2025 | FY2026 May 2026 |
|---|---|---|---|---|---|
| Net Income | 48.31M | (22.87M) | (9.42M) | (1.09B) | (7.9M) |
| Depreciation & Amortization | 24.13M | 90.47M | 121.23M | 125.67M | 116.3M |
| Deferred Income Tax | (4.7M) | (19.23M) | (27.42M) | (57.78M) | (24.3M) |
| Stock-Based Compensation | 7.15M | 10.18M | 13.77M | 17.29M | 13.4M |
| Change in Working Capital | (4.42M) | (24.2M) | (72.68M) | (5.93M) | 58.8M |
| Accounts Receivables | (7.8M) | (53.88M) | (20.1M) | 11.64M | 6.8M |
| Inventory | (21.07M) | 9.96M | (55.95M) | (16.12M) | 38.2M |
| Accounts Payables | 20.24M | 18.64M | 13.75M | (402K) | 19.8M |
| Other Working Capital | 4.21M | 1.09M | (10.38M) | (1.05M) | (6M) |
| Other Non-Cash Items | (2.44M) | 6.67M | 9.8M | 1.07B | (73.1M) |
| Operating Cash Flow | 68.04M | 41.03M | 35.26M | 58.24M | 83.2M |
| Capital Expenditures | (24.43M) | (65.76M) | (111.42M) | (104.6M) | (51.3M) |
| Acquisitions (Net) | (38.75M) | 12.55M | 108K | 5.08M | 121.7M |
| Purchases of Investments | (415.89M) | (12.52M) | 0 | 0 | 0 |
| Sales of Investments | 381.84M | 266.77M | 82M | 325K | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 100K |
| Investing Cash Flow | (97.23M) | 201.04M | (29.31M) | (99.2M) | 70.5M |
| Debt Repayment | 0 | (100M) | (420K) | (321K) | (100M) |
| Common Stock Issued | 7.93M | 1.2M | 2.46M | 2.24M | 1.6M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.12M) | (19.28M) | (118K) | (3.52M) | (1M) |
| Financing Cash Flow | 6.81M | (118.08M) | 1.92M | (1.6M) | (99.4M) |
| Effect of Forex Changes | (8.75M) | (5.22M) | (502K) | 942K | 2.2M |
| Net Change in Cash | (31.13M) | 118.77M | 7.37M | (41.61M) | 56.5M |
| Free Cash Flow | 43.61M | (24.73M) | (76.16M) | (46.35M) | 31.9M |
Neogen Corporation
NASDAQ:NEOG
Intrinsic Alpha fair value
Locked
Current Price
$11.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.